loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Efavirenz

    Client Email Product
    Menu

    Efavirenz

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 95Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20972 / DOSAGE - CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EFAVIRENZ(UNII: JE6H2O27P8)
    (EFAVIRENZ - UNII:JE6H2O27P8)     		EFAVIRENZ50mg | 200mg

    Inactive Ingredients

    Ingredient Name
    Aesica Queenborough Limited
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    SODIUM LAURYL SULFATE(368GB5141J)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)